Table 2 Odds ratios (95% confidence interval) for respiratory symptom outcomes estimated by multivariable logistic regression among 472 patients hospitalized for confirmed COVID-19 infection

Age (years)

1.02 (1.01–1.03); 0.001

0.99 (0.98–1.01); 0.48

1.02 (1.01–1.03); < 0.0001

1.03 (1.02–1.04); < 0001

1.00 (0.98–1.02); 0.86

0.97 (0.95–0.99); 0.005

Age-group (years)

 < 15

Ref

Ref

Ref

Ref

Ref

Ref

15–34

0.88 (0.21–3.63); 0.86

0.53 (0.10–2.74); 0.45

0.69 (0.17–2.84); 0.61

0.33 (0.08–1.44); 0.14

NE

2.15 (0.22–20.70; 0.51

35–59

1.27 (0.31–5.09); 0.74

0.69 (0.14–3.44); 0.65

1.28 (0.32–5.11); 0.73

0.51 (0.13–2.09); 0.35

1.29 (0.41–3.98); 0.66

3.51 (0.23–54.25); 0.37

 > 60

1.90 (0.47–7.66); 0.37

0.48 (0.09–2.47); 0.38

1.54 (0.38–6.20); 0.54

1.56 (0.38–6.27); 0.53

1.47 (0.61–3.55); 0.38

7.20 (0.23–227.3); 0.26

Sex

Female

Ref

Ref

Ref

Ref

Ref

Ref

Male

1.55 (1.0–2.40); 0.05

1.10 (0.60–2.03); 0.86

1.29 (0.82–2.05); 0.27

0.77 (0.48–1.23); 0.27

2.26 (0.90–5.65); 0.08

0.94 (0.47–1.85); 0.85

Profession

Pupil/student

Ref

Ref

Ref

Ref

Ref

Ref

Public Servant/Administration

1.31 (0.52–3.30);0.56

2.51 (0.67–9.35); 0.17

0.77 (0.30–1.94); 0.58

1.17 (0.39–3.52); 0.77

1.15 (0.10–12.86); 0.91

8.82 (1.66–46.91); 0.01

Housekeeper/None

0.61 (0.19–1.9); 0.40

1.24 (0.25–6.13); 0.79

0.56 (0.19–1.69); 0.31

0.91 (0.26–3.18); 0.88

4.89 (0.34–70.78); 0.24

3.23 (0.46–23.35); 0.25

Private

1.22 (0.51–2.92); 0.65

2.36 (0.68–8.10); 0.17

0.74 (0.31–1.75); 0.50

0.89 (0.31–2.58); 0.83

2.31 (0.22–23.82); 0.48

2.69 (0.52–13.89); 0.24

Health workers

1.18 (0.48–2.97); 0.71

1.94 (0.53–7.09); 0.32

0.76 (0.31–1.92); 0.49

0.66 (0.21–2.04); 0.47

0.63 (0.05–8.83); 0.73

5.49 (1.07–28.21); 0.04

Travel last 14 days

No

Ref

Ref

Ref

Ref

Ref

Ref

Yes

0.34 (0.21–0.66); 0.001

1.12 (0.578–2.18); 0.74

0.44 (0.25–0.79); 0.006

0.42 (0.21–0.85); 0.017

1.06 (0.21–5.33); 0.94

0.21 (0.06–0.73); 0.013

Any Comorbidity

No

Ref

Ref

Ref

Ref

Ref

Ref

Yes

1.59 (1.03–2.45); 0.04

0.85 (0.45–1.61); 0.62

1.49 (0.96–2.30); 0.08

2.03 (1.27–3.26); 0.003

0.80 (0.35–1.85); 0.61

1.07 (0.51–2.21); 0.87

 ≥ 2 Comorbidities

No

Ref

Ref

Ref

Ref

Ref

Ref

Yes

1.18 (0.90–1.55); 0.21

NE

1.19 (0.91–1.54); 0.20

1.09 (0.84–1.41); 0.50

NE

NE

Time symptoms-consultation

1.04 (0.99–1.09); 0.09

0.99 (0.92–1.07); 0.84

1.06 (1.01–1.11); 0.02

1.04 (0.98–1.09); 0.20

1.05 (0.96–1.15); 0.23

1.02 (0.95–1.11); 0.55